{"id":3334,"date":"2018-12-07T13:16:23","date_gmt":"2018-12-07T12:16:23","guid":{"rendered":"http:\/\/jcet.eu\/new\/?p=3334"},"modified":"2019-01-02T13:41:25","modified_gmt":"2019-01-02T12:41:25","slug":"3334","status":"publish","type":"post","link":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/","title":{"rendered":"PRELUDIUM 15 w badaniach niewydolno\u015bci serca"},"content":{"rendered":"<p><strong>Z przyjemno\u015bci\u0105 informujemy o sukcesie kolejnego cz\u0142onka zespo\u0142u badawczego Jegiello\u0144skiego Centrum Rozwoju Lek\u00f3w (JCET). Pani Tasnim Mohaissen otrzyma\u0142a finansowanie z\u00a0<a href=\"https:\/\/www.ncn.gov.pl\/\" target=\"_blank\" rel=\"noopener\">Narodowego Centrum Nauki<\/a> (NCN) w Krakowie na realizacj\u0119 projektu pt.: <em>&#8222;Rola Angiotensyna (1-12) oraz szlaku niezale\u017cnego od ACE w produkcji Ang II w dysfunkcji \u015br\u00f3db\u0142onka naczy\u0144 obowodowych w niewydolno\u015bci serca&#8221;<\/em>, w ramach proglamu PRELUDIUM 15.<\/strong><\/p>\n<p>Niniejszy projekt zak\u0142ada precyzyjne po\u0142\u0105czenie technik\u00a0 farmakologicznych, analitycznych i biochemicznych, kt\u00f3re pozwoli na zbadanie alternatywnych dr\u00f3g produkcji angiotensyny (Ang\u00a0II) w celu poszukiwania nowych terapii niewydolno\u015bci mi\u0119\u015bnia sercowego.\u00a0 Angiotensyna II jest g\u0142\u00f3wnym produktem dzia\u0142ania ACE (ang. Angiotensin-Converting Enzyme &#8211; konwertaza angiotensyny) i jej nadprodukcja uwa\u017cana jest za kluczowy czynnik wzmagaj\u0105cy w\u0142\u00f3knienie i stany zapalne mie\u015bnia sercowego. W efekcie sprzyja to upo\u015bledzeniu nie tylko czynno\u015bci serca, ale ca\u0142ego uk\u0142adu sercowo-naczyniowego. Niestety, terapia polegaj\u0105ca na zmniejszeniu st\u0119\u017cenia osoczowej Ang\u00a0II, ogranicza \u015bmiertelno\u015b\u0107 pacjent\u00f3w i \u0142agodzi objawy choroby jedynie w cz\u0119\u015bci przypadk\u00f3w (brak jej skuteczno\u015bci u pacjent\u00f3w z zachowan\u0105 frakcj\u0105 wyrzutow\u0105). Ponadto, u wielu pacjent\u00f3w pomimo pocz\u0105tkowego spadku st\u0119\u017cenia Ang II, obserwuje si\u0119 jej ponowny wzrost po pewnym czasie trwania terapii, tzw. \u201eAng II escape\u201d. St\u0105d te\u017c konieczne wydaje si\u0119 opracowanie bardziej skutecznej terapii, a przede wszystkim lepsze zrozumienie mechanizm\u00f3w odpowiedzialnych za niekorzystne efekty zbyt mocno aktywowanego uk\u0142adu RAAS. G\u0142\u00f3wnym celem tego projektu jest ocena alternatywnych szlak\u00f3w syntezy Ang II w rozwoju obwodowej dysfunkcji \u015br\u00f3db\u0142onka w modelu niewydolno\u015bci serca.\u00a0Wci\u0105\u017c\u00a0 nie s\u0105 dobrze poznane mechanizmy odgrywaj\u0105ce rol\u0119 w niewydolno\u015bci serca o etiologii innej ni\u017c niedokrwiennej. Analiza obwodowej dysfunkcji \u015br\u00f3db\u0142onka, szczeg\u00f3lnie pod k\u0105tem jej mechanizm\u00f3w, jest istotna ze wzgl\u0119du na jej znaczenie prognostyczne i terapeutyczne w zaburzeniach sercowo-naczyniowych.<\/p>\n<ul>\n<li><strong>Bud\u017cet:\u00a0<\/strong>209 999 PLN<strong><br \/>\n<\/strong><\/li>\n<li><strong>Okes realizacji:\u00a0<\/strong>36 miesi\u0119cy<\/li>\n<\/ul>\n<p><a href=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3335\" src=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png\" alt=\"\" width=\"810\" height=\"450\" srcset=\"https:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png 810w, https:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim-300x167.png 300w, https:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim-768x427.png 768w\" sizes=\"auto, (max-width: 810px) 100vw, 810px\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.ncn.gov.pl\/aktualnosci\/2018-11-16-wyniki-opus15-preludium15\" target=\"_blank\" rel=\"noopener\">Wyniki konkursu PRELUDIUM 15 dost\u0119pne na stronie NCN.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Z przyjemno\u015bci\u0105 informujemy o sukcesie kolejnego cz\u0142onka zespo\u0142u badawczego Jegiello\u0144skiego Centrum Rozwoju Lek\u00f3w (JCET). Pani Tasnim Mohaissen otrzyma\u0142a finansowanie z\u00a0Narodowego Centrum Nauki (NCN) w Krakowie na realizacj\u0119 projektu pt.: &#8222;Rola Angiotensyna (1-12) oraz szlaku niezale\u017cnego od ACE w produkcji Ang<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[72,71,10,74,45,30,41,70,73,33],"class_list":["post-3334","post","type-post","status-publish","format-standard","hentry","category-viaria","tag-angiotensyna","tag-farmakologia","tag-jcet","tag-krazenie","tag-lab","tag-nauka","tag-ncn","tag-preludium","tag-serce","tag-srodblonek"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET\" \/>\n<meta property=\"og:description\" content=\"Z przyjemno\u015bci\u0105 informujemy o sukcesie kolejnego cz\u0142onka zespo\u0142u badawczego Jegiello\u0144skiego Centrum Rozwoju Lek\u00f3w (JCET). Pani Tasnim Mohaissen otrzyma\u0142a finansowanie z\u00a0Narodowego Centrum Nauki (NCN) w Krakowie na realizacj\u0119 projektu pt.: &#8222;Rola Angiotensyna (1-12) oraz szlaku niezale\u017cnego od ACE w produkcji Ang\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/\" \/>\n<meta property=\"og:site_name\" content=\"JCET\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jcet.eu\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-07T12:16:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-02T12:41:25+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png\" \/>\n<meta name=\"author\" content=\"Agnieszka Gudek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agnieszka Gudek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/\"},\"author\":{\"name\":\"Agnieszka Gudek\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/person\\\/13f485a795141f65ed056cb5e2b88f9e\"},\"headline\":\"PRELUDIUM 15 w badaniach niewydolno\u015bci serca\",\"datePublished\":\"2018-12-07T12:16:23+00:00\",\"dateModified\":\"2019-01-02T12:41:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/\"},\"wordCount\":331,\"publisher\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Tasnim.png\",\"keywords\":[\"angiotensyna\",\"farmakologia\",\"jcet\",\"kr\u0105\u017cenie\",\"lab\",\"nauka\",\"NCN\",\"preludium\",\"serce\",\"\u015br\u00f3db\u0142onek\"],\"articleSection\":[\"Varia\"],\"inLanguage\":\"pl-PL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/\",\"name\":\"PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Tasnim.png\",\"datePublished\":\"2018-12-07T12:16:23+00:00\",\"dateModified\":\"2019-01-02T12:41:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#primaryimage\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Tasnim.png\",\"contentUrl\":\"https:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Tasnim.png\",\"width\":810,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2018\\\/12\\\/07\\\/3334\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRELUDIUM 15 w&nbsp;badaniach niewydolno\u015bci serca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#website\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\",\"name\":\"JCET\",\"description\":\"Centrum doskona\u0142o\u015bci w farmakologii \u015br\u00f3db\u0142onka.\",\"publisher\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jcet.eu\\\/new\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\",\"name\":\"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/JCET-logo.png\",\"contentUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/JCET-logo.png\",\"width\":715,\"height\":401,\"caption\":\"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/jcet.eu\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/person\\\/13f485a795141f65ed056cb5e2b88f9e\",\"name\":\"Agnieszka Gudek\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/author\\\/agag\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/","og_locale":"pl_PL","og_type":"article","og_title":"PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET","og_description":"Z przyjemno\u015bci\u0105 informujemy o sukcesie kolejnego cz\u0142onka zespo\u0142u badawczego Jegiello\u0144skiego Centrum Rozwoju Lek\u00f3w (JCET). Pani Tasnim Mohaissen otrzyma\u0142a finansowanie z\u00a0Narodowego Centrum Nauki (NCN) w Krakowie na realizacj\u0119 projektu pt.: &#8222;Rola Angiotensyna (1-12) oraz szlaku niezale\u017cnego od ACE w produkcji Ang","og_url":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/","og_site_name":"JCET","article_publisher":"https:\/\/www.facebook.com\/jcet.eu\/","article_published_time":"2018-12-07T12:16:23+00:00","article_modified_time":"2019-01-02T12:41:25+00:00","og_image":[{"url":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png","type":"","width":"","height":""}],"author":"Agnieszka Gudek","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"Agnieszka Gudek","Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#article","isPartOf":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/"},"author":{"name":"Agnieszka Gudek","@id":"https:\/\/jcet.eu\/new\/#\/schema\/person\/13f485a795141f65ed056cb5e2b88f9e"},"headline":"PRELUDIUM 15 w badaniach niewydolno\u015bci serca","datePublished":"2018-12-07T12:16:23+00:00","dateModified":"2019-01-02T12:41:25+00:00","mainEntityOfPage":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/"},"wordCount":331,"publisher":{"@id":"https:\/\/jcet.eu\/new\/#organization"},"image":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png","keywords":["angiotensyna","farmakologia","jcet","kr\u0105\u017cenie","lab","nauka","NCN","preludium","serce","\u015br\u00f3db\u0142onek"],"articleSection":["Varia"],"inLanguage":"pl-PL"},{"@type":"WebPage","@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/","url":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/","name":"PRELUDIUM 15 w badaniach niewydolno\u015bci serca &#187; JCET","isPartOf":{"@id":"https:\/\/jcet.eu\/new\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#primaryimage"},"image":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png","datePublished":"2018-12-07T12:16:23+00:00","dateModified":"2019-01-02T12:41:25+00:00","breadcrumb":{"@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#primaryimage","url":"https:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png","contentUrl":"https:\/\/jcet.eu\/new\/wp-content\/uploads\/2018\/12\/Tasnim.png","width":810,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/jcet.eu\/new\/2018\/12\/07\/3334\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/jcet.eu\/new\/"},{"@type":"ListItem","position":2,"name":"PRELUDIUM 15 w&nbsp;badaniach niewydolno\u015bci serca"}]},{"@type":"WebSite","@id":"https:\/\/jcet.eu\/new\/#website","url":"https:\/\/jcet.eu\/new\/","name":"JCET","description":"Centrum doskona\u0142o\u015bci w farmakologii \u015br\u00f3db\u0142onka.","publisher":{"@id":"https:\/\/jcet.eu\/new\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jcet.eu\/new\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/jcet.eu\/new\/#organization","name":"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)","url":"https:\/\/jcet.eu\/new\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/jcet.eu\/new\/#\/schema\/logo\/image\/","url":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2022\/06\/JCET-logo.png","contentUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2022\/06\/JCET-logo.png","width":715,"height":401,"caption":"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)"},"image":{"@id":"https:\/\/jcet.eu\/new\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/jcet.eu\/"]},{"@type":"Person","@id":"https:\/\/jcet.eu\/new\/#\/schema\/person\/13f485a795141f65ed056cb5e2b88f9e","name":"Agnieszka Gudek","url":"https:\/\/jcet.eu\/new\/author\/agag\/"}]}},"_links":{"self":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/3334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/comments?post=3334"}],"version-history":[{"count":5,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/3334\/revisions"}],"predecessor-version":[{"id":3340,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/3334\/revisions\/3340"}],"wp:attachment":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/media?parent=3334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/categories?post=3334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/tags?post=3334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}